Grouping tickers under a single sector label is convenient, but it can also blur real differences. Of the five names in this headline, only two, AXT Inc and SanDisk, are semiconductor companies in the conventional sense. The other three stretch the definition of electronic …
Grouped headlines like this one usually come from an automated screen, and this batch is a good example of why a human read still matters. Of the five names, only Kanzhun genuinely sits insideBusinessand commercial services. Wise is a cross-border payments company that serves …
Healthcare inside theNasdaqComposite in September 2026 is not one story but several running at once. At the top of the barbell sit companies already turning products into profits. At the other end sit earlier-stage names still spending to prove a market exists. Tarsus Pharmaceuticals …
RHYTHM PHARMACEUTICALS, INC. (NASDAQ: RYTM) CEO David P. Meeker exercised options for 50,000 shares at $6.05 per share on 14 September 2026. The transaction was followed by sales of the same number of shares across five transactions at prices ranging from $101.75 to $105.19 …
● GeneDx grew exome and genomeVolume32% year over year to 30,785 results in the second quarter of 2026, reached adjustedNet Incomeof $0.4 million, and reiterated full-yearRevenueguidance of $475 million to $490 million.
Sionna Therapeutics, Inc. (NASDAQ: SION) plans to reduce its workforce by approximately 46% and expects about $6.4 million in restructuring and related charges.
Opaleye Management, Sol-Gel Technologies’ 10% owner, bought 3,124 shares at prices ranging from $65.94 to $66.80 per share across two transactions. The purchases left Opaleye with 540,000 shares, giving investors the disclosed transaction range and resulting ownership position for assessing the scale of the …
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Chairman Camblong Jurgi sold 8,500 shares at $7.66 per share on September 10, 2026. The transaction was reported under SEC transaction code S.
Vera Therapeutics, Inc. (NASDAQ: VERA) finance chief accounting officer Young Joseph R exercised options for 5,000 shares at $3.94 per share.
Crane Company (NYSE: CR) agreed to acquire the U.S. pump business of First Reserve-backed Trillium Flow Technologies for approximately $240 million. Its equipment base supports service, repair, retrofit and replacementDemandover the asset lifecycle.